Skip to search.
 TSX Up 0.44% TSX Ventures Up 0.66%

NeurogesX, Inc. (NGSX)

-Other OTC
0.01 0.00(0.00%) Jun 29, 10:32AM EDT
|After Hours : 0.28 0.00 (0.00%) 4:13PM EDT - Nasdaq Real Time Price
Add to Portfolio
Prev Close:0.01
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:1.00
Beta:1.52
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:0.00 - 0.02
Volume:0
Avg Vol (3m):N/A
Market Cap:216.66k
P/E (ttm):N/A
EPS (ttm):-0.96
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for NGSX at this time.

Comparison

Symbol% ChgMkt Cap
NGSX 0.00%216.66k
LLYDown 0.35%88.42B
ENDPUp 1.61%16.30B
PFEDown 0.18%206.47B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (0-00-31) :N/A
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

NeurogesX, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel non-opioid, pain management therapies to address unmet medical needs. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback